2006
DOI: 10.1097/01.ccm.0000207346.56477.e8
|View full text |Cite
|
Sign up to set email alerts
|

Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice*

Abstract: This study provides evidence, for the first time, that erythropoietin attenuates the degree of zymosan-induced nonseptic shock in mice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
41
1
3

Year Published

2010
2010
2014
2014

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(47 citation statements)
references
References 55 publications
2
41
1
3
Order By: Relevance
“…More recently, studies have indicated that EPO has cytoprotective effects in experimental models of inflammation and sepsis. In a murine model of zymosan-induced inflammation and organ failure, treatment with EPO attenuated lung, liver, and pancreatic injury; renal dysfunction; and mortality (15). Pretreatment with EPO before LPS administration in a rat model of lung injury attenuated histological lung injury and edema, and …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…More recently, studies have indicated that EPO has cytoprotective effects in experimental models of inflammation and sepsis. In a murine model of zymosan-induced inflammation and organ failure, treatment with EPO attenuated lung, liver, and pancreatic injury; renal dysfunction; and mortality (15). Pretreatment with EPO before LPS administration in a rat model of lung injury attenuated histological lung injury and edema, and …”
Section: Discussionmentioning
confidence: 99%
“…EPO, a hematopoietic growth factor with antiapoptotic properties, has been shown to have cytoprotective effects in various organs and tissues (14,15,17). We previously demonstrated that EPO attenuates splenic and thymic apoptosis in an endotoxic sepsis model (18).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Results from these studies are conflicting and appear dependent on variables in experimental conditions such as the inflammatory process under investigation (sepsis, infectious, ischemia-reperfusion), EPO dose level, and timing of EPO delivery. Anti-inflammatory (Cuzzocrea et al 2006;Aoshiba et al 2009), proinflammatory (Wu et al 2010), and a lack of immune-modulating effects (Solling et al 2011) have been reported. The increased neutrophils (AMG 114 high-and low-dose groups) and fibrinogen (high-dose group only) at 6 and/or 24 hr in the AMG 114 high-and low-dose groups, respectively, are features of an acute inflammatory response.…”
Section: Discussionmentioning
confidence: 99%
“…Zimosan, akut peritonit, septik olmayan şok ve artrit gibi enflamatuvar hastalıkları tetikleyen, bakteriyel ve endotoksik olmayan bir moleküldür (11)(12)(13)(14).…”
Section: Zimosanın Patofizyolojik Olaylardaki Rolüunclassified